Rhythm Pharmaceuticals Inc. (RYTM) Business Metric Overview

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Rhythm Pharmaceuticals In... (RYTM)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

53.66

-0.28 (-0.52%)

At close: Jan 15, 2025, 11:12 AM

Rhythm Pharmaceuticals Inc. Revenue Breakdown

Quarter	Mar 31, 2024
Product Revenue	25.97M
Product Revenue Growth	n/a

Revenue by Geography

Quarter	Dec 31, 2023
Germany Revenue	6.08M
Germany Revenue Growth	n/a
Other Countries Revenue	8.93M
Other Countries Revenue Growth	n/a
United States Revenue	62.42M
United States Revenue Growth	n/a

Operating Expense Breakdown

Quarter	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015	Jun 30, 2015	Mar 31, 2015
Selling, General, and Administrative Revenue	35.38M	36.41M	34.38M	32.37M	30.48M	30.05M	24.63M	26.32M	21.94M	22.33M	21.45M	21.00M	17.51M	15.46M	14.52M	13.12M	11.29M	8.92M	12.80M	9.41M	10.54M	8.84M	7.76M	8.39M	8.54M	6.44M	4.71M	4.33M	2.31M	1.36M	1.52M	2.74M	982.00K	1.11M	1.47M	2.02M	922.00K	239.00K	239.00K
Selling, General, and Administrative Revenue Growth	-2.85%	+5.91%	+6.20%	+6.23%	+1.43%	+21.97%	-6.40%	+19.96%	-1.75%	+4.10%	+2.15%	+19.93%	+13.20%	+6.52%	+10.66%	+16.21%	+26.54%	-30.28%	+35.93%	-10.64%	+19.16%	+13.95%	-7.50%	-1.77%	+32.65%	+36.52%	+8.89%	+87.04%	+70.60%	-10.49%	-44.75%	+179.43%	-11.77%	-24.39%	-27.31%	+119.63%	+285.77%	n/a	n/a
Research and Development Revenue	37.93M	30.02M	128.47M	29.89M	33.57M	33.54M	37.95M	23.55M	21.12M	31.46M	32.51M	31.57M	27.54M	25.10M	19.91M	21.95M	23.00M	23.00M	22.50M	24.81M	26.57M	35.31M	22.76M	18.76M	10.71M	8.58M	12.29M	6.65M	5.97M	5.40M	4.87M	5.63M	5.42M	4.53M	4.01M	3.62M	2.20M	666.00K	666.00K
Research and Development Revenue Growth	+26.37%	-76.64%	+329.79%	-10.96%	+0.08%	-11.60%	+61.14%	+11.52%	-32.87%	-3.24%	+2.96%	+14.65%	+9.70%	+26.08%	-9.31%	-4.53%	-0.01%	+2.19%	-9.29%	-6.63%	-24.74%	+55.12%	+21.31%	+75.27%	+24.71%	-30.13%	+84.67%	+11.42%	+10.64%	+10.75%	-13.46%	+3.91%	+19.52%	+13.07%	+10.83%	+64.60%	+230.03%	n/a	n/a